Since its inception in 1993, the McDonnell Genome Institute has received over $1.3 billion in research funding.
Research from the institute is published in the world’s top scientific journals, including Nature, Science and the New England Journal of Medicine.
From contributing 25% of the finished sequence to the Human Genome Project to sequencing the first cancer genome, MGI’s research continues to advance the diagnosis, treatment and prevention of disease.
Areas of research at MGI include:
- Cancer genomics
- Technology development
- Genomics of common diseases
- Human genome reference improvement
- Infectious diseases